Regeneron Pharmaceuticals (REGN) Interest Coverage Ratio (2009 - 2026)

Regeneron Pharmaceuticals' Interest Coverage Ratio history runs 18 years deep, the most recent figure standing at 24.64 for Q2 2026.

• In Q2 2026, Interest Coverage Ratio fell 76.72% year-over-year to 24.64; the TTM figure through Jun 2026 stood at 73.2 (down 80.56% YoY), while the FY2025 annual figure was 28.85, up 359.41% from the prior year.
• Interest Coverage Ratio for Q2 2026 stood at 24.64, up from 22.72 in the prior quarter.
• The five-year high for Interest Coverage Ratio was 125.34 in Q4 2024, with the low at 3.53 in Q3 2022.
• The 5-year median for Interest Coverage Ratio is 23.68 (2026), against an average of 36.8.
• The sharpest annual moves came in 2022 and 2024: Interest Coverage Ratio plunged 98.31% in 2022, then surged 814.66% in 2024.
• Regeneron Pharmaceuticals' Interest Coverage Ratio stood at 65.91 in 2022, then dropped by 19.77% to 52.88 in 2023, then soared by 137.05% to 125.34 in 2024, then declined by 29.8% to 87.99 in 2025, then slumped by 72.0% to 24.64 in 2026.
• Business Quant data shows REGN's Interest Coverage Ratio at 24.64 in Q2 2026, 22.72 in Q1 2026, and 87.99 in Q4 2025.